Clozapine Use Among Individuals With Schizophrenia Occurring on the Background of Intellectual Disability and Rare Genetic Variation
This study affirms what is known about clozapine treatment in 22q11.2 deletion syndrome, adds to the scarce literature on Usher syndrome in this context, and provides the first accounts of clozapine use in 22q11.2 microduplication syndrome and DCX variant-related heterotopia.
Authors
- Mark Ainsley Colijn (ORCID: https://orcid.org/0000-0002-8151-1173)
Institutions
- Allen Institute for Brain Science (US)
Publication Details
- Journal
- Journal of Clinical Psychopharmacology
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1097/jcp.0000000000002000
- Citations
- 2
- Primary Topic
- Genomic variations and chromosomal abnormalities
- Type
- article
- Field-Weighted Citation Impact
- 3.63